Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced positive six-month findings from the single-arm AVG cohort of its WRAPSODY Arteriovenous Access ...
There is a new class I recommendation for statin therapy in all CABG patients, unless contraindicated. Hormone replacement therapy should no longer be initiated in women after CABG. The new ...